KR20170053793A - Method for production of fermented ginseng berry extract with improved anti-oxidant activity - Google Patents
Method for production of fermented ginseng berry extract with improved anti-oxidant activity Download PDFInfo
- Publication number
- KR20170053793A KR20170053793A KR1020150155911A KR20150155911A KR20170053793A KR 20170053793 A KR20170053793 A KR 20170053793A KR 1020150155911 A KR1020150155911 A KR 1020150155911A KR 20150155911 A KR20150155911 A KR 20150155911A KR 20170053793 A KR20170053793 A KR 20170053793A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng fruit
- extract
- fruit extract
- fermented
- fermented ginseng
- Prior art date
Links
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 131
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 128
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 128
- 239000000284 extract Substances 0.000 title claims abstract description 97
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 43
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 241000208340 Araliaceae Species 0.000 title claims abstract 14
- 235000021028 berry Nutrition 0.000 title abstract description 7
- 238000000855 fermentation Methods 0.000 claims abstract description 23
- 230000004151 fermentation Effects 0.000 claims abstract description 23
- 230000036541 health Effects 0.000 claims abstract description 15
- 235000013376 functional food Nutrition 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims description 107
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 15
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 15
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 12
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 11
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 11
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 238000009631 Broth culture Methods 0.000 claims description 2
- 235000020710 ginseng extract Nutrition 0.000 claims description 2
- 240000004371 Panax ginseng Species 0.000 description 117
- 230000000052 comparative effect Effects 0.000 description 10
- 230000009471 action Effects 0.000 description 9
- 235000013305 food Nutrition 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000186016 Bifidobacterium bifidum Species 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229930182494 ginsenoside Natural products 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000003809 water extraction Methods 0.000 description 5
- 235000002789 Panax ginseng Nutrition 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229940089161 ginsenoside Drugs 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000006993 memory improvement Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 101800000414 Corticotropin Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- AGBCLJAHARWNLA-DQUQINEDSA-N Ginsenoside RG2 Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@@](C)(O)CCC=C(C)C)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O AGBCLJAHARWNLA-DQUQINEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003178 anti-diabetic effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 2
- 229960000258 corticotropin Drugs 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229940111782 egg extract Drugs 0.000 description 2
- 229940068517 fruit extracts Drugs 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 2
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 2
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 2
- CDUFCUKTJFSWPL-UHFFFAOYSA-L manganese(II) sulfate tetrahydrate Chemical compound O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O CDUFCUKTJFSWPL-UHFFFAOYSA-L 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 2
- 239000001393 triammonium citrate Substances 0.000 description 2
- 235000011046 triammonium citrate Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- AGBCLJAHARWNLA-UHFFFAOYSA-N (20R)-ginsenoside Rg2 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C3C(C)(C)C(O)CCC3(C)C3C(C4(CCC(C4C(O)C3)C(C)(O)CCC=C(C)C)C)(C)C2)OC(CO)C(O)C1O AGBCLJAHARWNLA-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- 241000207965 Acanthaceae Species 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 1
- UZIOUZHBUYLDHW-XUBRWZAZSA-N ginsenoside Rf Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZIOUZHBUYLDHW-XUBRWZAZSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- JURZHOVRCOWZFN-UHFFFAOYSA-N notoginsenoside R1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(COC7OCC(O)C(O)C7O)C(O)C(O)C6O)C JURZHOVRCOWZFN-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 230000027517 positive regulation of hormone secretion Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000021749 root development Effects 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A23Y2220/35—
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 인삼열매 추출물을 발효균주로 발효시키는 단계를 포함하는 항산화 활성이 증가된 발효 인삼열매 추출물의 제조방법 및 상기 발효 인삼열매 추출물을 포함하는 항산화 활성이 증가된 건강기능식품에 관한 것이다. The present invention relates to a method for preparing a fermented ginseng fruit extract having an increased antioxidant activity, which comprises fermenting a ginseng fruit extract to a fermenting germ, and a health functional food having increased antioxidant activity including the fermented ginseng fruit extract.
인삼은 다년생 반음지성 식물로 오가피과에 속하는 식물로서 한국, 중국 및 일본 등지에서 2,000여년 전부터 사용되어 온 생약이며, 경험적으로 질병을 예방하고 수명을 연장시킬 목적으로 사용되어 왔다. 지금까지 알려진 인삼의 효능 및 효과는 중추신경계에 대한 작용, 항발암 작용, 항암활성, 면역기능 조절작용, 항당뇨 작용, 간기능 개선, 심혈관 장애개선, 항동맥경화 작용, 혈압조절 작용, 갱년기 장애 개선, 골다공증 개선, 항스트레스 및 항피로 작용, 항산화 활성 및 노화억제 효능 등이 있다(최신고려인삼 '성분 및 효능편', 한국인삼연초연구원, 56-112, 1996). Ginseng is a herbaceous perennial herbaceous plant belonging to the acanthaceae family. It has been used in Korea, China and Japan for over 2,000 years and has been used for the purpose of preventing disease and prolonging life span. The efficacy and effects of ginseng so far known include the action on the central nervous system, the anticarcinogenic action, the anti-cancer activity, the immune function regulation action, the anti-diabetic action, the liver function improvement, the cardiovascular disorder improvement, the anti-arteriosclerosis action, (Korean Ginseng & Tobacco Research Institute, 56-112, 1996), which is the most recent Korean ginseng ingredient and its efficacy.
현대에 와서 인삼에 대해 널리 연구한바, 인삼에는 다량의 진세노사이드(ginsenoside)가 함유되어 있는 것으로 알려져 약재 이외에도, 근래에는 식품에 적용하여 건강식품의 재료로 많이 사용하고 있다.It is known that ginseng contains a large amount of ginsenoside. In addition to medicines, it has recently been applied to foods and is widely used as a material for health foods.
인삼의 대표적 생리활성 성분인 진세노사이드(ginsenoside)는 인삼의 지상 및 지하부에 고르게 분포되어 있으며, 특히 인삼 근(뿌리), 인삼엽 및 인삼열매 등 부위에 따라 진세노사이드 함량뿐만 아니라 조성도 다른 것으로 알려져 있다(Attele AS et al, Biochem Pharmacol, 58; 1685-1693, 1999).Ginsenoside, which is a representative physiologically active ingredient of ginseng, is distributed evenly on the ground and underground of ginseng. Especially, depending on the parts such as ginseng roots, ginseng leaves and ginseng fruits, not only ginsenoside content but also composition (Attele AS et al, Biochem Pharmacol, 58: 1685-1693, 1999).
인삼의 효능물질인 사포닌은 배당체에서 당이 아닌 부분이 고리 화합물로 Saponin, which is an effective substance of ginseng,
이루어진 것의 총칭인데, 인삼에는 사포닌 중 진세노사이드 Rb1, Rb2, Rh1, Rh2, Rg1, Rg2, Rg3, Re, Rc 등이 함유되어, 체내에서 다양한 효능을 나타낸다. Popov 등의 연구 결과에 따르면, 인삼을 섭취할 경우, 코르티코트로핀(corticotrophin), 코르티솔(cortisol) 등의 호르몬 분비가 증가하고, 유의적인 피로 회복 기능성이 있다고 보고되었다. 진세노사이드 Rh2, Rg3 등은 면역자극제로, 외부 자극인자에 대항하는 비특이적 방어작용을 강화하는 효과가 있다. Ginseng contains ginsenosides Rb1, Rb2, Rh1, Rh2, Rg1, Rg2, Rg3, Re, and Rc in saponin and exhibits various effects in the body. Popov et al. Have reported that when ginseng is consumed, the hormone secretion of corticotrophin, cortisol and the like increases and has significant fatigue recovery function. Ginsenosides Rh2, Rg3, etc. are immunostimulants and have the effect of enhancing nonspecific defense against external stimuli.
구체적으로, 사포닌 별 약리작용은 다음과 같다. 진세노사이드 Rb1은 중추신경 억제, 진통작용, 혈청 단백질 합성 촉진, 중성지방분해의 콜레스테롤 합성 촉진, 호르몬 분비 촉진, 간 기능에 도움을 주는 기능이 있고, Rb2는 당뇨조절, 비만 및 동맥경화 방지, 중추신경 억제작용, 유전인자 합성 촉진, 플라스민 활성화, 코르티코트로핀과 코르티솔의 분비 촉진, 항당뇨 작용을 하며, 진세노사이드 Rc는 중추신경억제, 혈청 단백질 합성 촉진, 플라스민 활성화, 코르티코트로핀과 코르티솔의 분비 촉진의 작용을 하며, 진세노사이드 Rg1은 중추신경 흥분, 항피로, 피로회복, 기억력 증진, 당뇨조절, 비만 방지 등의 작용을 하고, 진세노사이드 Rg2는 혈소판 응집억제, 플라스민 활성화, 기억력 증진의 작용을 한다. 이 밖에도 진세노사이드 Rf, Ro, Rd 등이 지질과산화억제, 뇌신경세포 진통작용, 알코올해독, 염증치료 등의 작용을 나타낸다. 홍삼이 갖는 다양한 기능 중, 면역력 증진, 피로개선, 혈소판 응집억제를 통한 혈액흐름 개선, 기억력 개선, 항산화 등의 약리작용은 널리 인정되고 있다.Specifically, the pharmacological action of saponin is as follows. Ginsenoside Rb1 has the function of inhibiting central nervous system, analgesic action, promotion of serum protein synthesis, promotion of cholesterol synthesis of triglycerol decomposition, stimulation of hormone secretion, liver function, Rb2 is a function of diabetes control, prevention of obesity and arteriosclerosis, Cyclosporine and cortisol secretion, antidiabetic action, and ginsenoside Rc inhibits central nervous system, stimulates serum protein synthesis, activates plasmin, inhibits corticotropin, And ginsenoside Rg1 acts as a stimulant for central nervous system stimulation, anti-fatigue, fatigue recovery, memory enhancement, diabetes control, and prevention of obesity. Ginsenoside Rg2 acts as an inhibitor of platelet aggregation, Activation, and memory enhancement. In addition, ginsenosides Rf, Ro, and Rd inhibit lipid peroxidation, cranial nerve cell analgesia, alcohol detoxification, treatment of inflammation and other actions. Among various functions of red ginseng, pharmacological actions such as improvement of immunity, improvement of fatigue, improvement of blood flow through inhibition of platelet aggregation, improvement of memory and antioxidation are widely recognized.
한편, 인삼의 줄기와 잎은 광합성을 통해 뿌리 발달에 영향을 주지만, 열매는 오히려 영양분을 소모하여 뿌리 생육을 저해하여 폐기되는 부산물로 알려져 있다. 그러나 최근 인삼 열매의 진세노사이드 함량이 뿌리보다 높다는 연구결과가 밝혀지면서, 건강기능식품 및 미용분야에서 인삼열매 관련 제품에 대한 연구개발이 활발히 이루어지고 있다.On the other hand, the stem and leaf of ginseng affect the root development through photosynthesis, but the fruit is known as a byproduct which is consumed nutrients and inhibits root growth and is discarded. Recently, however, research on ginseng fruit-related products has been actively conducted in the fields of health functional foods and cosmetics, as researches have revealed that the ginsenoside content of the ginseng fruits is higher than the roots.
이에, 본 발명자들은 종래 폐기되었던, 인삼열매를 이용하여 원래 인삼 열매가 가지고 있는 항산화 활성을 보다 강화시키기 위해 예의 노력한 결과, 인삼열매 추출물을 제조한 후 상기 인삼열매 추출물에 다양한 발효균주를 이용하여 발효시켜 얻은 발효 인삼열매 추출물이 기존에 인삼열매가 가지고 있는 항산화 효과를 현저히 향상시킴을 확인하여 본 발명을 완성하였다.As a result of intensive efforts to enhance the antioxidant activity of the original ginseng fruit using the previously discarded ginseng fruit, the inventors of the present invention have found that the ginseng fruit extract is prepared, and then the ginseng fruit extract is subjected to fermentation The present inventors completed the present invention by confirming that the fermented ginseng fruit extract obtained by the present invention significantly improved the antioxidative effect of the ginseng fruit.
본 발명의 하나의 목적은 인삼열매 추출물을 발효균주로 발효시키는 단계를 포함하는 항산화 활성이 증가된 발효 인삼열매 추출물의 제조방법을 제공하는 것이다. One object of the present invention is to provide a method for preparing a fermented ginseng fruit extract having an increased antioxidant activity, comprising the step of fermenting a ginseng fruit extract to a fermenting germ.
본 발명의 다른 하나의 목적은 상기 발효 인삼열매 추출물을 포함하는 항산화 활성이 증가된 건강기능식품을 제공하는 것이다.It is another object of the present invention to provide a health functional food having an increased antioxidative activity including the fermented ginseng fruit extract.
본 발명자들은 종래 폐기되었던, 인삼열매를 이용하여 원래 인삼 열매가 가지고 있는 항산화 활성을 보다 강화시키기 위해 예의 노력한 결과, 인삼열매 추출물을 제조한 후 상기 인삼열매 추출물에 다양한 발효균주를 이용하여 발효시켜 제조된 발효 인삼열매 추출물이 발효되지 않은 인삼열매에 비해 항산화 효과가 현저히 향상됨을 확인하여 본 발명을 완성하였다.As a result of intensive efforts to enhance the antioxidant activity of the original ginseng fruit using the previously discarded ginseng fruit, the inventors of the present invention prepared a ginseng fruit extract and fermented the ginseng fruit extract using various fermentation strains The present inventors completed the present invention by confirming that the antioxidative effect of the fermented ginseng fruit extract was significantly improved compared to the ginseng fruit not fermented.
상기의 목적을 달성하기 위해, 본 발명은 하나의 양태로서, 인삼열매 추출물을 발효균주로 발효시키는 단계를 포함하는 항산화 활성이 증가된 발효 인삼열매 추출물의 제조방법을 제공한다. In order to achieve the above object, the present invention provides, as one embodiment, a method for producing a fermented ginseng fruit extract having an increased antioxidant activity, which comprises fermenting a ginseng fruit extract to a fermenting germ.
본 발명의 발효 인삼열매 추출물은 발효되지 않은 인삼열매 추출물에 비해 항산화 활성이 증가되는 것을 특징으로 하는데, 발효 인삼열매 추출물의 증가된 항산화 활성은 발효 전후의 인삼열매 추출물을 대상으로 항산화 활성을 측정하여 확인할 수 있다. The fermented ginseng fruit extract of the present invention is characterized by an increase in antioxidant activity compared to the non-fermented ginseng fruit extract. The antioxidant activity of the ginseng fruit extract before and after fermentation was measured by the fermented ginseng fruit extract Can be confirmed.
본 발명의 용어 "인삼열매(人參果, Panax ginseng C. A. Meyter)"는 진생베리(Ginseng berry)라고도 하며, 1년 중 7월 중순경 약 일주일 동안만 4년생 이상의 인삼에서 열리는 열매이다. 현재까지 인삼열매는 주로 폐기의 대상이였으나, 본 발명에서와 같이 인삼열매의 추출물을 발효균주로 발효시켜 제조된 발효 인삼열매 추출물이 발효되지 않은 단순 인삼열매 추출물보다 현저히 높은 항산화활성을 가지는 것을 확인한 연구는 거의 없었다.The term " Panax ginseng C. A. Meyter "of the present invention is also called " Ginseng berry ", and is a fruit that is present in ginseng more than four years old for about one week in the middle of July of the year. However, it has been confirmed that the extract of the fermented ginseng fruit prepared by fermenting the extract of the ginseng fruit as the present invention has a remarkably high antioxidant activity than that of the non-fermented ginseng fruit extract, .
한편, 본 발명에 있어서, 상기 인삼열매 추출물은 당업계에 공지된 통상의 방법에 따라, 즉, 통상적인 온도와 압력의 조건하에서, 통상적인 용매를 사용하여 제조될 수 있다. 상기 인삼열매 추출물은 당업계에 공지된 일반적인 추출방법, 분리 및 정제방법을 이용하여 제조할 수 있다. 상기 추출방법으로는, 이에 제한되지는 않으나, 열탕 추출, 열수 추출, 냉침 추출, 환류 냉각 추출 또는 초음파 추출 등의 방법을 사용할 수 있다.On the other hand, in the present invention, the ginseng fruit extract can be produced by a conventional method known in the art, that is, under the conditions of ordinary temperature and pressure, using a conventional solvent. The ginseng fruit extract can be prepared by using common extraction, isolation and purification methods known in the art. Examples of the extraction method include, but are not limited to, hot water extraction, hot water extraction, cold extraction, reflux cooling extraction, or ultrasonic extraction.
상기 인삼열매 추출물은 인삼열매를 대상으로 물, 탄소수 1 내지 4의 저급 알코올, 에틸아세테이트 및 이들의 혼합용매로 구성된 군으로부터 선택되는 용매로 추출될 수 있다. 이에 제한되지 않지만, 보다 구체적으로, 물을 용매로 사용하여 추출하여 수득한 결과물일 수 있으며, 상기 결과물은 추출액, 추출액의 희석액 또는 농축액, 추출액을 건조하여 얻어지는 건조물, 또는 이들 조정제물 또는 정제물 등을 포함한다.The ginseng fruit extract may be extracted from a ginseng fruit using a solvent selected from the group consisting of water, lower alcohol having 1 to 4 carbon atoms, ethyl acetate, and a mixed solvent thereof. But it is not limited thereto. More specifically, it may be an extract obtained by extracting with water as a solvent, and the resultant product may be a diluted solution or concentrate of the extract, a dried product obtained by drying the extract, .
본 발명의 일실시예에서는 세척된 인삼열매를 탈피기를 이용하여 씨를 분리하였으며, 씨가 제거된 인삼열매에 5 내지 10배의 물을 가하여 90~95℃에서 6 내지 10시간 열수추출한 다음 여과한 후 20 내지 60℃의 온도에서 600 내지 1000 mmHg의 조건에서 진공 농축하여 인삼열매 추출물을 제조하였다. In one embodiment of the present invention, the seeds of the washed ginseng were removed using a stripping machine, 5 to 10 times of water was added to the seedless ginseng fruit, and the extract was subjected to hot water extraction at 90 to 95 ° C for 6 to 10 hours, And concentrated under vacuum at a temperature of 20 to 60 DEG C under a pressure of 600 to 1000 mmHg to prepare a ginseng fruit extract.
본 발명에서 용어 "발효균주"는 인삼열매 추출물의 발효에 사용되는 균주를 의미하며, 인삼열매 추출물을 발효시킬 수 있는 한, 이에 제한되지 않지만, 비피도박테리움 락티스(Bifidobacterium lactis), 락토바실러스 애시도필러스(Lactobacillus acidophilus), 락토바실러스 람노서스(Lactobacillus rhamnosus), 스트렙토코커스 써모필러스(Streptococcus thermophilus), 락토바실러스 카제이(Lactobacillus casei), 및 락토바실러스 퍼멘툼(Lactobacillus fermentum)으로 이루어진 군에서 선택될 수 있다. The term "fermentation strain" in the present invention means a strain used for fermentation of the ginseng fruit extract, and includes, but is not limited to, bifidobacterium lactisBifidobacterium lactis), Lactobacillus acidophilus (Lactobacillus acidophilus), Lactobacillus lambatus (Lactobacillus rhamnosus), Streptococcus thermophilus (Streptococcus thermophilus), Lactobacillus casei (Lactobacillus casei), And Lactobacillus fermentum (Lactobacillus fermentum). ≪ / RTI >
상기 비피도박테리움 락티스(Bifidobacterium lactis)는 면역물질을 생성하도록 자극하고 과민성대장증후군, 염증성 질환에 효과적이다. The Bifidobacterium lactis (Bifidobacterium lactis ) stimulates to produce an immune substance and is effective in irritable bowel syndrome, inflammatory diseases.
상기 락토바실러스 람노서스(Lactobacillus rhamnosus)는 면역 조절 효과가 뛰어나며, 내산성이 강해 장 정착력이 높으며 유해균의 침입을 억제한다.The above-mentioned Lactobacillus rhamnosus is excellent in immunomodulating effect, is strong in acid resistance, has a high fixing ability and inhibits the invasion of harmful bacteria.
상기 스트렙토코커스 써모필러스(Streptococcus thermophilus)는 항생제에 민감한 특징을 가진다.The Streptococcus thermophilus is characterized by antibiotic sensitivity.
상기 락토바실러스 퍼멘툼(Lactobacillus fermentum)은 인체의 내장이나 질, 입 안에 적응해 정착하여 살고 있는 소화 유산균이지만, 자연계에서 널리 발견되는 유산균 종의 하나로 발효 중인 식물이나 동물 속에서 주로 발견된다.The Lactobacillus fermentum is a digestive lactobacillus which is established and adapted to the internal organs, vagina and mouth of the human body. However, it is one of the lactic acid bacteria widely found in nature and is found mainly in plants or animals which are fermenting.
본 발명에서, 항산화 활성을 증가시키기 위해서 상기 인삼열매 추출물 대비 107 내지 108 CFU/mL의 농도를 가지는 발효균주 배양액 1%(v/v)를 접종하여 30 내지 40℃에서 1 내지 30시간 동안 또는 보다 구체적으로, 34 내지 37℃에서 2 내지 28시간 배양하여 발효 인삼열매 추출물을 제조할 수 있다. In the present invention, in order to increase the antioxidant activity, 1% (v / v) of a fermentation broth culture having a concentration of 10 7 to 10 8 CFU / mL is added to the ginseng fruit extract and incubated at 30 to 40 ° C for 1 to 30 hours More specifically, the fermented ginseng fruit extract can be prepared by culturing at 34 to 37 ° C for 2 to 28 hours.
본 발명의 일실시예에서는 상기 인삼열매 추출물에 107 내지 108 CFU/mL의 농도를 가지는 발효균주 배양액을 인삼열매 추출물 대비 1%(v/v)로 접종하고, 온도 35℃의 조건을 유지하면서 24시간 동안 배양하여 발효 인삼열매 추출물을 얻었다.In one embodiment of the present invention, the culture broth of the fermentation broth having a concentration of 10 7 to 10 8 CFU / mL is inoculated to the ginseng fruit extract at 1% (v / v) relative to the ginseng fruit extract and maintained at a temperature of 35 ° C And cultured for 24 hours to obtain a fermented ginseng fruit extract.
본 발명의 용어 “항산화”란, 좁은 범위로는 체내에서 생성되는 자유라디칼, 상기 자유라디칼로부터 생선되는 과산화수소 또는 과산화물, 상기 과산화수소로부터 생성되는 하이드록시 라디칼의 생성 또는 반응을 억제, 감소 또는 제어하는 작용을 의미하고, 넓은 범위로는 자연계에서 발생하는 산화반응의 생성을 억제, 감소 또는 제어하는 작용을 의미한다. 본 발명의 목적상, 상기 항산화는 좁은 범위의 항산화로서 이해되고, 주로 세포수준에서 발생되는 자유라디칼 또는 과산화수소의 생성 또는 반응을 억제, 감소 또는 제어하는 작용으로서 이해될 수 있으나, 특별히 이에 제한되지는 않는다.The term " antioxidant " of the present invention means a free radical generated in the body in a narrow range, hydrogen peroxide or peroxide generated from the free radical, an action of suppressing, decreasing or controlling the generation or reaction of a hydroxy radical generated from the hydrogen peroxide , And a wide range means an action to inhibit, reduce or control the generation of an oxidation reaction occurring in the natural world. For purposes of the present invention, the antioxidant is understood as a narrow range of antioxidants and can be understood as an action that inhibits, reduces or controls the production or reaction of free radicals or hydrogen peroxide, which occurs mainly at the cellular level, but is not particularly limited thereto Do not.
본 발명의 일실시예에서는 발효되지 않은 비교예 1의 인삼열매 추출물과 비교하여 실시예 5의 락토바실러스 퍼멘툼(Lactobacillus fermentum)으로 발효된 발효 인삼열매 추출물의 발효시간에 따른 라디칼 소거능력 여부를 확인한 결과, 발효 24시간째에 항산화 활성이 가장 높은 것을 확인하였다(표 1 참조). In one embodiment of the present invention, it was confirmed that the extract of fermented ginseng fermented with Lactobacillus fermentum of Example 5 had a radical scavenging ability according to the fermentation time as compared with the ginseng fruit extract of Comparative Example 1 which was not fermented As a result, it was confirmed that the antioxidant activity was the highest at 24 hours after fermentation (see Table 1).
또한, 본 발명의 다른 일실시예에 의하면 인삼열매 추출물에 발효균주인 비피도박테리움 락티스(Bifidobacterium lactis), 락토바실러스 람노서스(Lactobacillus rhamnosus), 스트렙토코커스 써모필러스(Streptococcus thermophilus), 또는 락토바실러스 퍼멘툼(Lactobacillus fermentum)을 사용하여 발효한 발효 인삼열매 추출물은 발효되지 않은 인삼열매 추출물에 비해 항산화 활성이 현저히 높음을 확인하였다(표 2 참조). According to another embodiment of the present invention, the ginseng fruit extract may be supplemented with Bifidobacterium lactis ( Bifidobacterium lactis) fermented ginseng fruit extract fermented with lactis , Lactobacillus rhamnosus , Streptococcus thermophilus , or Lactobacillus fermentum showed higher antioxidant activity than non fermented ginseng fruit extract Activity was significantly high (see Table 2).
특히 상기 발효균주 중에서, 락토바실러스 퍼멘툼(Lactobacillus fermentum)은 비피도박테리움 락티스(Bifidobacterium lactis), 락토바실러스 람노서스(Lactobacillus rhamnosus), 또는 스트렙토코커스 써모필러스(Streptococcus thermophilus)에 비해 항산화 활성이 상대적으로 증가된 것을 확인하였다. Particularly, among the above fermentation strains, Lactobacillus fermentum is Bifidobacterium lactis ( Bifidobacterium lactis ) lactic acid, Lactobacillus rhamnosus , or Streptococcus thermophilus . The results are shown in Table 1 .
본 발명은 다른 하나의 양태로서, 상기 발효 인삼열매 추출물을 포함하는 항산화 활성이 증가된 건강기능식품을 제공한다.In another aspect of the present invention, there is provided a health functional food having an increased antioxidant activity including the fermented ginseng fruit extract.
본 발명의 용어, "건강기능식품"이란, 특정보건용 식품(food for special health use, FoSHU)와 동일한 용어로, 영양 공급 외에도 생체조절기능이 효율적으로 나타나도록 가공된 의학, 의료효과가 높은 식품을 의미하며, 경우에 따라 건강식품, 기능성식품, 건강보조식품 등의 용어와 혼용될 수 있다. 본 발명의 목적상 상기 건강기능식품은 항산화 활성을 나타내어 이를 섭취한 개체의 건강을 유지, 개선 또는 회복에 유용한 효과를 얻기 위하여 제조될 수 있으며, 이들의 제품 형태는 바람직하게는 정제, 캅셀, 분말, 과립, 액상, 환 등의 다양한 형태로 제조될 수 있으나, 특별히 이제 제한되지는 않는다.The term "health functional food" as used herein means the same food as the food for special health use (FoSHU). In addition to nutrition, And may be used in combination with terms such as health food, functional food, and health supplement food in some cases. For the purpose of the present invention, the health functional food may be prepared in order to exhibit antioxidative activity and to obtain effects useful for maintaining, improving or recovering the health of an individual ingested. The product form thereof is preferably tablets, capsules, powders , Granules, liquids, rings, and the like, but is not particularly limited thereto.
상기 발효 인삼열매 추출물을 식품 첨가물로 사용할 경우, 상기 발효 인삼열매 추출물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 사용 목적 (예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다.When the fermented ginseng fruit extract is used as a food additive, the fermented ginseng fruit extract may be directly added or used together with other food or food ingredients, and may be suitably used according to a conventional method. The amount of the active ingredient to be mixed can be suitably determined according to the intended use (prevention, health or therapeutic treatment).
상기 식품의 종류에는 특별한 제한은 없다. 상기 발효 인삼열매 추출물을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the kind of the food. Examples of foods to which the fermented ginseng fruit extract can be added include dairy products including meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, other noodles, gums, ice cream, , A drink, an alcoholic beverage, and a vitamin complex, all of which include health foods in a conventional sense.
상기 외에 본 발명의 건강기능식품은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 본 발명의 건강기능식품은 천연 과일쥬스, 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다.In addition to the above, the health functional food of the present invention may contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and its salts, organic acids, protective colloid thickeners, pH adjusters, stabilizers, Alcohols, carbonating agents used in carbonated drinks, and the like. In addition, the health functional food of the present invention may contain natural fruit juice, fruit juice beverage and flesh for the production of vegetable beverages.
본 발명은 인삼열매 추출물에 발효균주인 비피도박테리움 락티스(Bifidobacterium lactis), 락토바실러스 람노서스(Lactobacillus rhamnosus), 스트렙토코커스 써모필러스(Streptococcus thermophilus), 또는 락토바실러스 퍼멘툼(Lactobacillus fermentum)을 이용하여 발효한 발효 인삼열매 추출물은 발효되지 않은 인삼열매 추출물에 비해 항산화 활성이 높으므로, 이를 이용한 항산화 활성이 증가된 건강기능식품 제조에 유용하게 사용될 수 있다. The present invention relates to a method for producing ginseng fruit by using Bifidobacterium lactis , Lactobacillus rhamnosus , Streptococcus thermophilus , or Lactobacillus fermentum , Fermented ginseng fruit extract has higher antioxidant activity than non - fermented ginseng fruit extract and can be useful for the production of health functional foods with increased antioxidant activity.
도 1은 발효 인삼열매 추출물과 발효되지 않은 인삼열매 추출물의 항산화 활성을 비교한 것이다.FIG. 1 compares the antioxidative activities of fermented ginseng fruit extract and non-fermented ginseng fruit extract.
이하, 본 발명을 하기 실시예에서 보다 구체적으로 설명한다. 그러나 이들 예는 본 발명의 이해를 돕기 위한 것일 뿐, 이들에 의해 본 발명이 한정되는 것은 아니다.Hereinafter, the present invention will be described more specifically in the following examples. However, these examples are provided only to aid understanding of the present invention, and the present invention is not limited thereto.
1. 실험재료의 준비 및 실험방법1. Preparation of experimental material and experimental method
1.1 인삼열매의 가공 및 인삼열매 추출물의 제조1.1 Processing of ginseng fruit and production of ginseng fruit extract
세척된 인삼열매를 탈피기를 이용하여 씨를 분리하여 제거한 인삼열매에 물을 이용하여 90~95℃에서 8시간 열수 추출한 후, 여과된 추출액을 20 내지 60℃온도에서, 600 내지 1000mmHg 조건에서 진공 농축하여 원료로 사용하였다. The washed ginseng fruit was separated from the seeds by using a stripping machine, and the extracted ginseng fruit was subjected to hot water extraction at 90 to 95 ° C for 8 hours using water. The filtered extract was concentrated in vacuo at a temperature of 20 to 60 ° C under 600 to 1000 mmHg And used as a raw material.
1.2 발효 균주 및 발효 조건1.2 Fermentation Strain and Fermentation Conditions
상기 본 발명의 인삼열매 또는 씨앗을 발효시키기 위한 발효균주를 선별하였으며, 인삼열매 또는 씨앗을 발효시키기 위한 균주로, 비피도박테리움 락티스(Bifidobacterium lactis), 락토바실러스 람노서스(Lactobacillus rhamnosus), 스트렙토코커스 써모필러스(Streptococcus thermophilus), 비피도박테리움 비피덤(Bifidobacterium bifidum), 락토바실러스 퍼멘툼(Lactobacillus fermentum)을 사용하였다. A fermentation strain for fermenting the ginseng fruit or seed of the present invention was selected and as a strain for fermenting the ginseng fruit or seed, Bifidobacterium lactis , Lactobacillus rhamnosus , Streptococcus thermophilus , Bifidobacterium bifidum , and Lactobacillus fermentum were used.
상기 균주를 MRS-agar plate(1.0 % peptone, 0.8 % egg extract, 0.4 % yeast extract, 2.0 % glucose, 0.5 % sodium acetate trihydrate, 0.1 % polysorbate 80, 0.2 % dipotassium hydrogen phosphate, 0.2 % triammonium citrate, 0.02 % magnesium sulfate heptahydrate, 0.005 % manganese sulfate tetrahydrate, 및 1.0 % agar)에 접종하여 stock plate를 만들고 MRS broth (10.0 g/L peptone, 8.0 g/L egg extract, 4.0 g/L yeast extract, 20.0 g/L glucose, 5.0 g/L sodium acetate trihydrate, 2.0 g/L dipotassium hydrogen phosphate, 2.0 g/L triammonium citrate, 0.2 g/L magnesium sulfate heptahydrate, 및 0.05 g/L manganese sulfate tetrahydrate)에 3회 계대 배양한 배양액을 준비하였다. The strain was cultured on MRS agar plate (1.0% peptone, 0.8% egg extract, 0.4% yeast extract, 2.0% glucose, 0.5% sodium acetate trihydrate, 0.1
상기 배양액에 함유된 균주의 농도는 107 내지 108 CFU/mL로 준비하여, 인삼열매 추출물의 발효에 사용되었다. The concentration of the strain contained in the culture solution was adjusted to 10 7 to 10 8 CFU / mL and used for the fermentation of the ginseng fruit extract.
1.3 항산화 활성 실험(1.3 Antioxidant Activity Test DPPHDPPH assay) assay)
상기 균주들을 이용하여 인삼열매 추출물의 최적발효시간을 정한 후 발효 균주별로 발효된 인삼열매 농축액의 항산화 효과를 비교하였다. 최적발효조건은 발효 인삼열매 농축액의 항산화 효과를 비교하여 탐색하였다.The optimal fermentation time of ginseng fruit extracts was determined by using the above strains and the antioxidative effect of fermented ginseng fruit concentrate was compared. The optimum fermentation conditions were investigated by comparing the antioxidative effect of fermented ginseng fruit concentrate.
1,1-Diphenyl-2-picrylhydrazyl radical (DPPH, 0.2mM)을 함유한 메탄올 용액에 100μg/Ml의 시험물질을 혼합한 후 실온에서 30분간 반응 후 517nm에서 흡광도를 측정하여 시험물질 간 라디칼 소거능을 비교 분석하였다.After mixing 100 μg / Ml of the test substance in a methanol solution containing 1,1-diphenyl-2-picrylhydrazyl radical (DPPH, 0.2 mM), the absorbance was measured at 517 nm for 30 minutes at room temperature and the radical scavenging ability Respectively.
이하에서는 상기와 같은 실험방법을 이용하여, 아래와 같이 인삼열매 추출물을 제조하고, 그 활성을 실험하였다.Hereinafter, the extract of the ginseng fruit was prepared as described below and its activity was tested using the above-mentioned experimental method.
비교예Comparative Example 1: 인삼열매 추출물의 제조 1: Preparation of ginseng fruit extract
인삼열매를 수확하여 정제수로 세척하여 이물질을 제거한 후 탈피기를 이용해 씨를 분리하여 제거하여 인삼열매를 준비하였다. 씨가 제거된 인삼열매에 물을 가하여 90~95℃에서 8시간 열수 추출한 후, 여과된 추출액을 20 내지 60℃ 온도에서, 600 내지 1000mmHg 조건에서 진공 농축하여 인삼열매 추출물을 얻었다.The ginseng fruit was harvested and washed with purified water to remove the foreign material. Then, the seeds were removed by using a stripping machine to prepare ginseng fruit. Water was added to the extracted ginseng fruit, and the extract was subjected to hot water extraction at 90 to 95 ° C for 8 hours. Then, the filtered extract was vacuum concentrated at a temperature of 20 to 60 ° C under a vacuum of 600 to 1000 mmHg to obtain a ginseng fruit extract.
실시예Example 1: One: BifidobacteriumBifidobacterium lactislactis 를To 이용한 발효 인삼열매 추출물의 제조 Preparation of Fermented Ginseng Fruit Extract Using
상기 비교예 1의 인삼열매 추출물에 107 내지 108 CFU/mL의 농도를 가지는 비피도박테리움 락티스(Bifidobacterium lactis) 배양액을 인삼열매 추출물 대비 1%(v/v)로 접종하고, 온도 35℃의 조건을 유지하면서 24시간 동안 배양하여 발효 인삼열매 추출물을 얻었다.To the ginseng fruit extract of Comparative Example 1, Bifidobacterium ( Bifidobacterium) having a concentration of 10 7 to 10 8 CFU / lactis were inoculated with 1% (v / v) of ginseng fruit extract and incubated for 24 hours at 35 ℃ to obtain fermented ginseng fruit extract.
실시예Example 2: 2: Lactobacillus Lactobacillus rhamnosusrhamnosus 를To 이용한 발효 인삼열매 추출물의 제조 Preparation of Fermented Ginseng Fruit Extract Using
상기 비교예 1의 인삼열매 추출물에 107 내지 108 CFU/mL의 농도를 가지는 락토바실러스 람노서스(Lactobacillus rhamnosus) 배양액을 인삼열매 추출물 대비 1%(v/v)로 접종하고, 온도 35℃의 조건을 유지하면서 24시간 동안 배양하여 발효 인삼열매 추출물을 얻었다.The Lactobacillus rhamnosus culture solution having a concentration of 10 7 to 10 8 CFU / mL was inoculated into the ginseng fruit extract of Comparative Example 1 at a concentration of 1% (v / v) relative to the ginseng fruit extract, The fermented ginseng fruit extract was obtained by culturing for 24 hours while maintaining the conditions.
실시예Example 3: 3: Streptococcus Streptococcus thermophilusthermophilus 를To 이용한 발효 인삼열매 추출물의 제조 Preparation of Fermented Ginseng Fruit Extract Using
상기 비교예 1의 인삼열매 추출물에 107 내지 108 CFU/mL의 농도를 가지는 스트렙토코커스 써모필러스(Streptococcus thermophilus) 배양액을 인삼열매 추출물 대비 1%(v/v)로 접종하고, 온도 35℃의 조건을 유지하면서 24시간 동안 배양하여 발효 인삼열매 추출물을 얻었다.The culture solution of Streptococcus thermophilus having a concentration of 10 7 to 10 8 CFU / mL was inoculated in 1% (v / v) of the ginseng fruit extract to the ginseng fruit extract of Comparative Example 1, , And cultured for 24 hours to obtain a fermented ginseng fruit extract.
실시예Example 4: 4: BifidobacteriumBifidobacterium bifidumbifidum 을of 이용한 발효 인삼열매 추출물의 제조 Preparation of Fermented Ginseng Fruit Extract Using
상기 비교예 1의 인삼열매 추출물에 107 내지 108 CFU/mL의 농도를 가지는 비피도박테리움 비피덤(Bifidobacterium bifidum) 배양액을 인삼열매 추출물 대비 1%(v/v)로 접종하고, 온도 35℃의 조건을 유지하면서 24시간 동안 배양하여 발효 인삼열매 추출물을 얻었다.BP betting having a concentration of 10 7 to 10 8 CFU / mL for the ginseng extract of the fruit of the Comparative Example 1, Te Solarium bipyridinium bushes (Bifidobacterium bifidum ) was inoculated with 1% (v / v) of the ginseng fruit extract and cultured for 24 hours at 35 ° C to obtain a fermented ginseng fruit extract.
실시예Example 5: 5: Lactobacillus Lactobacillus fermentumfermentum 을of 이용한 발효 인삼열매 추출물의 제조 Preparation of Fermented Ginseng Fruit Extract Using
상기 비교예 1의 인삼열매 추출물에 107 내지 108 CFU/mL의 농도를 가지는 락토바실러스 퍼멘툼(Lactobacillus fermentum) 배양액을 인삼열매 추출물 대비 1%(v/v)로 접종하고, 온도 35℃의 조건을 유지하면서 24시간 동안 배양하여 발효 인삼열매 추출물을 얻었다.The culture of Lactobacillus fermentum having a concentration of 10 7 to 10 8 CFU / mL was inoculated into the ginseng fruit extract of Comparative Example 1 at a concentration of 1% (v / v) relative to the ginseng fruit extract, The fermented ginseng fruit extract was obtained by culturing for 24 hours while maintaining the conditions.
실험예Experimental Example 1: One: DPPHDPPH 항산화 실험 Antioxidant experiment
DPPH 소거 활성 측정은 항산화 활성을 측정하는데 사용하는 실험으로 DPPH라는 산화제로 산화를 개시한 후 샘플(sample)에 의해서 라티칼(radical)에 대한 소거 능력을 측정하는 실험이다.DPPH scavenging activity is an experiment used to measure antioxidant activity. It is an experiment to measure the scavenging ability of radicals by a sample after initiating oxidation with DPPH oxidizing agent.
아래의 표 1에 나타난 바와 같이 반응 개시 30분 후 비교예 1의 인삼열매 추출물과 실시예 5의 락토바실러스 퍼멘툼(Lactobacillus fermentum)를 이용한 발효 인삼열매 추출물의 발효시간에 따른 라디칼 소거능력 여부를 확인한 결과, 발효 24시간째 항산화 활성이 가장 높은 것을 알 수 있었다. As shown in the following Table 1, 30 minutes after the initiation of the reaction, it was confirmed whether the extract of the ginseng fruit of Comparative Example 1 and the extract of the fermented ginseng fruit of Lactobacillus fermentum of Example 5 had a radical scavenging ability according to fermentation time As a result, it was found that the antioxidant activity was the highest at 24 hours after fermentation.
또한, 비교예 1의 인삼열매 추출물과 비피도박테리움 락티스(Bifidobacterium lactis), 락토바실러스 람노서스(Lactobacillus rhamnosus), 스트렙토코커스 써모필러스(Streptococcus thermophilus), 비피도박테리움 비피덤(Bifidobacterium bifidum), 또는 락토바실러스 퍼멘툼(Lactobacillus fermentum)를 이용한 발효 인삼열매 추출물의 발효균주별 라디칼 소거능력 여부를 확인한 결과, 비피도박테리움 비피덤(Bifidobacterium bifidum)을 이용한 발효 인삼열매 추출물을 제외하고 나머지 4개의 균주를 이용한 발효 인삼열매 추출물은 발효되지 않은 비교예 1의 인삼열매 추출물에 비해 1.3 내지 2 배 이상의 우수한 항산화 효과가 있음을 확인하였다. In addition, the ginseng fruit extract of Comparative Example 1, Bifidobacterium lactis , Lactobacillus rhamnosus , Streptococcus thermophilus , Bifidobacterium bifidum , , Or Lactobacillus fermentum was used to examine the ability of the fermented ginseng fruit extract to radical scavenging by fermentation strains. As a result, Bifidobacterium ( Bifidobacterium bifidum) bifidum ), the fermented ginseng fruit extract using the remaining four strains was found to have an excellent antioxidative effect of 1.3 to 2 times or more as compared with the ginseng fruit extract of Comparative Example 1 which was not fermented.
이와 같은 결과는 인삼열매 추출물에 있어서, 발효 균주의 종류에 따라 항산화 효과가 상이함을 시사하는 것이다. 특히 비피도박테리움 비피덤(Bifidobacterium bifidum)에 의해서 발효된 인삼열매 추출물은 발효되지 않은 인삼열매 추출물에 비해 항산화 효과가 낮은 것을 알 수 있었다. These results suggest that the antioxidative effect of ginseng fruit extract varies depending on the fermentation strain. In particular, the extracts of ginseng fermented with Bifidobacterium bifidum showed lower antioxidative activities than those of non - fermented ginseng fruit extracts.
Claims (7)
A method for producing fermented ginseng fruit extract having increased antioxidant activity, comprising fermenting ginseng fruit extract to a fermenting germ.
The method according to claim 1, wherein the fermenting bacteria are selected from the group consisting of Bifidobacterium lactis , Lactobacillus rhamnosus , Streptococcus thermophilus , and Lactobacillus fermentum . Wherein the antioxidant activity of the fermented ginseng extract is increased.
[Claim 2] The method according to claim 1, wherein the fermenting bacteria is Lactobacillus fermentum .
The method according to claim 1, wherein the Lactobacillus fermentum is selected from the group consisting of Bifidobacterium wherein the antioxidant activity is relatively increased as compared to that of Lactobacillus rhamnosus or Streptococcus thermophilus . The present invention also relates to a method for producing fermented ginseng fruit extract having increased antioxidant activity.
The method according to claim 1, wherein 1% (v / v) of a fermentation broth having a concentration of 10 7 to 10 8 CFU / mL is inoculated with the ginseng fruit extract and cultured at 30 to 40 ° C for 1 to 30 hours , A method for producing an extract of a fermented ginseng fruit having an increased antioxidant activity.
The method according to claim 1, wherein 1% (v / v) of a fermentation broth culture having a concentration of 10 7 to 10 8 CFU / mL is inoculated with the ginseng fruit extract and cultured at 34 to 37 ° C for 2 to 28 hours , A method for producing an extract of a fermented ginseng fruit having an increased antioxidant activity.
A health functional food having increased antioxidant activity, comprising a fermented ginseng fruit extract prepared by the method of any one of claims 1 to 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150155911A KR20170053793A (en) | 2015-11-06 | 2015-11-06 | Method for production of fermented ginseng berry extract with improved anti-oxidant activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150155911A KR20170053793A (en) | 2015-11-06 | 2015-11-06 | Method for production of fermented ginseng berry extract with improved anti-oxidant activity |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20170053793A true KR20170053793A (en) | 2017-05-17 |
Family
ID=59048565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150155911A KR20170053793A (en) | 2015-11-06 | 2015-11-06 | Method for production of fermented ginseng berry extract with improved anti-oxidant activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20170053793A (en) |
-
2015
- 2015-11-06 KR KR1020150155911A patent/KR20170053793A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4163631B2 (en) | Fermentation composition of spicy varieties of chili pepper and its use | |
KR20160058389A (en) | Method of Manufacturing Volumizing Antocyanine Probiotics Metabolite and Pharmetics, cosmetics and Juice and food complex | |
KR20160130651A (en) | Composition for Anti-Diabetes and Eyesight Recovery Using Aronia Fruits and Mulberry | |
KR100998575B1 (en) | Pharmaceutical and health food composition comprising soy yogurt and fermented product of plant extracts, fermented kimchi lactic acid bacteria | |
KR20220136107A (en) | Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same | |
JP4119656B2 (en) | Antioxidant | |
KR101690779B1 (en) | A method for manufacturing fermented composition comprising red gingseng and rubus coreanus and the fermented composition by the method | |
TW201034584A (en) | Process for producing γ-aminobutyric acid-rich material | |
TWI734322B (en) | Kimchi for prevention or treatment of disease related to helicobacter pylori | |
KR20200084212A (en) | Anti-obesity composition comprising extract of Sargassum horneri | |
JP2020061977A (en) | Novel lactic acid bacterium that belongs to streptococcus salivarius, and use of the same | |
KR20170120264A (en) | Fermented chestnut puree of probiotic lactic acid bacteria and foods composition, medicinal composition including the same | |
KR20160060834A (en) | Compositions for culture media of Kefir grain comprising plant extract and compositions for improving skin conditions comprising fermented products using the same | |
KR20140072421A (en) | Anti-stress Composition | |
KR101945207B1 (en) | Method for manufacturing a composition for enhancing intestinal environment and composition manufactured by the method | |
KR20190072923A (en) | Antioxidant and Immune-enhancing functional beverage and food composition comprising the extract of edible flowers fermented by lactic acid bacteria and preparation method of the same | |
KR102030902B1 (en) | Fermentation method of lactic acid bacteria using fruit of Prunus sp. and its use | |
KR20220018649A (en) | Composition for improving stress, sleep disorder and maintaining deep sleep comprising lactic acid bacteria | |
KR101973514B1 (en) | Prebiotics Containing Grape seed flour | |
KR101924392B1 (en) | Method for Preparing Yogurt and the Yogurt Obtained Thereby | |
KR20170053793A (en) | Method for production of fermented ginseng berry extract with improved anti-oxidant activity | |
KR20090093619A (en) | Anti-helicobacter composition containing schizandra sp extract and rubus careabus extract | |
KR20160069119A (en) | Fermentation Process of a Garlic Using New Strain of Bacillus subtilis | |
JP2006265142A (en) | Body fat accumulation inhibiting or decreasing agent | |
JP7444368B1 (en) | New lactic acid bacteria belonging to Lactiplantibacillus plantarum isolated from tulip flowers and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |